IFNG and neoplasm: To determine whether tumor RNA-loaded CD40-B cells induced functional tumor-specific T cell responses in vivo, peripheral blood mononuclear cells (PBMC) obtained at the time of diagnosis and 3 weeks after the last vaccination were analyzed for the presence of IFN-γ producing, tumor-specific T cells by ELISPOT.